During the past decade, Glaucoma Consultants of the Capital Region conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Glaucoma Consultants of the Capital Region" #1 sponsor was "Aerie Pharmaceuticals" with 3 trials, followed by "InnFocus Inc." with 2 trials sponsored, "Allergan" with 1 trials sponsored, "Glaukos Corporation" with 1 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Glaucoma Consultants of the Capital Region" #1 collaborator was "Novartis" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Glaucoma Consultants of the Capital Region" are "Glaucoma" (3 trials), "Ocular Hypertension" (3 trials), "Glaucoma, Open-Angle" (2 trials), "Keratoconjunctivitis Sicca" (1 trials) and "Primary Open Angle Glaucoma" (1 trials). Many other conditions were trialed in "Glaucoma Consultants of the Capital Region" in a lesser frequency.

Most popular intervention types in "Glaucoma Consultants of the Capital Region" are "Drug" (5 trials), "Device" (2 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "0.004% Travoprost" (1 trials), "0.25% AR-12286 / 0.004% travoprost" (1 trials), "0.5% AR-12286, 0.004% travoprost" (1 trials), "AR-12286 0.25% Ophthalmic solution" (1 trials) and "AR-12286 0.5% ophthalmic solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Glaucoma Consultants of the Capital Region" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Glaucoma Consultants of the Capital Region". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Glaucoma Consultants of the Capital Region, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Glaucoma Consultants of the Capital Region, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".